Comparative Proteomic Analysis of Non-small-cell Lung Cancer and Normal Controls Using Serum Label-Free Quantitative Shotgun Technology

Author： Pan Jun  

Publisher： Springer Publishing Company

ISSN： 0341-2040

Source： Lung, Vol.186, Iss.4, 2008-08, pp. : 255-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Limitations in the Use of Serum Epidermal Growth Factor Receptor Mutations as Prognostic Markers for Non-Small-Cell Lung Cancer

By  

Medical Principles and Practice, Vol. 24, Iss. 5, 2015-06 ,pp. : 486-490

Karger

Access to resources Recommend Favorite

The impact of cardiovascular comorbidities on the outcome of surgery for non-small-cell lung cancer

By Takenaka Tomoyoshi   Katsura Masakazu   Shikada Yasunori   Tsukamoto Syuichi   Takeo Sadanori  

Interactive CardioVascular and Thoracic Surgery, Vol. 16, Iss. 3, 2013-03 ,pp. : 270-274

Oxford University Press

Access to resources Recommend Favorite

Combined Modality Treatment of Non-Small-Cell Lung Cancer

By Westeel V.   Depierre A.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 6, 2003-01 ,pp. : 477-490

Adis International

Access to resources Recommend Favorite

Surgical treatment of non-small-cell lung cancer in octogenarians

By Guerra Miguel   Neves Paulo   Miranda Jos  

Interactive CardioVascular and Thoracic Surgery, Vol. 16, Iss. 5, 2013-05 ,pp. : 673-680

Oxford University Press

Access to resources Recommend Favorite

Cetuximab-based Therapy is Effective in Chemotherapy-naïve Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials

By Ibrahim Ezzeldin  

Lung, Vol. 189, Iss. 3, 2011-06 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite